ApoA1/HDL and sepsis-associated vascular endothelial injury: a narrative review - Top-Institutions - MDSpire

ApoA1/HDL and sepsis-associated vascular endothelial injury: a narrative review

  • By

  • Kailin Guo

  • Chang Hu

  • Le Li

  • Xiao Liu

  • Yaohui Liu

  • Dongsu Zhang

  • Yujie Fang

  • Yiming Li

  • Bo Hu

  • October 8, 2025

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Critical Care Medicine
    • Vascular Biology
    • Immunology

  • #2

    Massachusetts General Hospital / Harvard Medical School
    Massachusetts General Hospital / Harvard Medical School

    Boston, MA

    Key Differentiators

    • Critical Care Medicine
    • Cardiovascular Medicine
    • Molecular Biology

  • #3

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Critical Care Medicine
    • Vascular Biology
    • Lipidology

  • #4

    University of Pittsburgh Medical Center (UPMC)
    University of Pittsburgh Medical Center (UPMC)

    Pittsburgh, PA

    Key Differentiators

    • Critical Care Medicine
    • Vascular Biology
    • Infectious Diseases

  • #5

    Washington University in St. Louis
    Washington University in St. Louis

    St. Louis, MO

    Key Differentiators

    • Critical Care Medicine
    • Vascular Biology
    • Immunology

Original Source(s)

ApoA1/HDL and sepsis-associated vascular endothelial injury: a narrative review

  • by Kailin Guo, Chang Hu, Le Li, Xiao Liu, Yaohui Liu, Dongsu Zhang, Yujie Fang, Yiming Li, Bo Hu

  • October 8, 2025

Related Content

Adjunctive acupuncture for sepsis-associated acute gastrointestinal injury: a systematic review, meta-analysis, and exploratory Bayesian network meta-analysis

Targeting VISTA for immunomodulation in sepsis: mechanisms and therapeutic potentials

FDA Clears AI Sepsis Warning System

An FDA-cleared AI tool developed at Johns Hopkins detects sepsis up to 48 hours earlier than clinicians — and has cut related deaths by 18%.